Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative estradiol gel continuation in transgender women undergoing gender-affirming surgery
ACTRN12621000022864Phase 4Withdrawn
- Sponsor
- University of Melbourne
- Start
- Feb 2021
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in gender dysphoria (GD) comparing Estrogel with Placebo gel (2 arms). Primary endpoint: Coagulability of blood. Planned start Feb 2021; status: withdrawn.
02
Drugs
estradiol
03
Conditions
gender dysphoria (GD)
Beyond the preview
Go deeper on ACTRN12621000022864.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12621000022864.